ApoA-I

Optimal result: 160 – 200 mg/dL

Elevated Apolipoprotein A‑I (ApoA‑I) levels are generally considered favorable and are often associated with a lower risk of cardiovascular disease. ApoA‑I is the main protein component of high‑density lipoprotein (HDL), or “good cholesterol,” and plays a key role in reverse cholesterol transport—removing excess cholesterol from tissues and delivering it to the liver for clearance. Higher ApoA‑I levels typically reflect more efficient cholesterol removal and better overall lipid metabolism and are often linked to protective factors such as regular physical activity, a healthy diet, and favorable metabolic health. Current evidence suggests that normal to moderately elevated ApoA‑I is cardioprotective, although extremely high levels are less well studied and may not always confer additional benefit. As with all lipid parameters, ApoA‑I should be interpreted in the context of the full lipid profile (including ApoB or the ApoB/ApoA‑I ratio) and the individual’s overall cardiovascular risk profile.

Decreased levels of ApoA-I, which signify lower concentrations of high-density lipoprotein (HDL) or "good cholesterol" in the blood, can indicate an increased risk for cardiovascular diseases, including heart attacks and strokes. When ApoA-I levels are low, it means there's less HDL available to transport cholesterol from the arteries to the liver for removal, leading to a buildup of cholesterol and other fats within the artery walls.

This buildup can eventually result in the formation of plaques, narrowing the arteries and making it harder for blood to flow through, a condition known as atherosclerosis.

The causes of low ApoA-I levels can be multifaceted, including genetic factors, lifestyle choices such as smoking, lack of exercise, unhealthy diet, obesity, and certain medical conditions like diabetes, kidney disease, or liver disease.

Symptoms of low ApoA-I levels might not be directly noticeable until a cardiovascular event occurs. However, individuals may experience symptoms related to the underlying causes or conditions, such as fatigue, chest pain, or shortness of breath from heart disease.

Diagnosing low ApoA-I levels typically involves blood tests as part of a broader lipid profile check during a routine health examination. If low ApoA-I levels are detected, further testing may be required to determine the underlying cause.

Treatment options focus on addressing the root cause and improving HDL levels. This can include lifestyle modifications like adopting a healthier diet rich in fruits, vegetables, and whole grains; increasing physical activity; quitting smoking; and losing weight if overweight. In some cases, medications such as statins, niacin, or fibrates may be prescribed to help manage cholesterol levels.

Monitoring and managing other health conditions like diabetes or hypertension are also crucial in treating low ApoA-I levels. Through a comprehensive approach that includes lifestyle changes and, if necessary, medication, it's possible to increase ApoA-I levels and reduce the risk of cardiovascular disease.

ApoA-I, or Apolipoprotein A-I, plays a crucial role in understanding heart health and managing potential risks related to cardiovascular diseases. ApoA-I is the main protein component of high-density lipoprotein (HDL) in the blood. HDL is often referred to as "good cholesterol" because it helps transport cholesterol from the arteries to the liver, where it can be processed and removed from the body. This process is essential for maintaining healthy artery walls and preventing the build-up of plaques that can lead to heart attacks and strokes. Higher levels of ApoA-I and consequently HDL are generally associated with a lower risk of heart disease. The measurement of ApoA-I in a lipid panel provides valuable information about a person's HDL levels and overall cardiovascular health. By assessing ApoA-I, healthcare providers can better understand an individual's risk for heart disease and tailor treatment plans to improve heart health, such as recommending lifestyle changes or prescribing medication to manage cholesterol levels effectively. 

ApoA-I, or Apolipoprotein A-I, plays a crucial role in understanding heart health and managing potential risks related to cardiovascular diseases. ApoA-I is the main protein component of high-density lipoprotein (HDL) in the blood. HDL is often referred to as "good cholesterol" because it helps transport cholesterol from the arteries to the liver, where it can be processed and removed from the body. This process is essential for maintaining healthy artery walls and preventing the build-up of plaques that can lead to heart attacks and strokes. Higher levels of ApoA-I and consequently HDL are generally associated with a lower risk of heart disease. The measurement of ApoA-I in a lipid panel provides valuable information about a person's HDL levels and overall cardiovascular health. By assessing ApoA-I, healthcare providers can better understand an individual's risk for heart disease and tailor treatment plans to improve heart health, such as recommending lifestyle changes or prescribing medication to manage cholesterol levels effectively. 

ApoA-I
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond ApoA-I — 10,000+ markers explained
One ApoA-I result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro